Because Heart Matters!

Welcome to Klavant GmbH – precision in healthcare

State of the art – Cardio Vascular AI MedTech

At Klavant, we envision a future where surgical outcomes are transformed by our state-of-the-art medical devices. Our commitment is to empower surgeons with unparalleled insights into their procedures, ultimately leading to more successful surgeries.

Our mission at Klavant is to pioneer advancements in surgical technology.

We are dedicated to developing and implementing cutting-edge digital intraoperative quality control systems and AI-based image-guided solutions for conventional heart surgeries.

Our focus is on improving the assessment of aortic valve competence post-SAVR procedures and aorta ascendens resections. By providing surgeons with the technology they need to enhance patient outcomes, we aim to revolutionize the field of surgery and contribute to better healthcare worldwide.


We are excited to share our latest press release, which marks an important milestone.

innovative and digital

artificial intelligence

performance measurement


Klavant is winner of ideas phase at Science4Life Venture Cup!

In the highly renowned Germany-wide Science4Life competition, which has been held for over 20 years, Klavant was awarded winner of the ideas phase in the Life Science Venture Cup category among around 60 participants.


1st place in the MedTech Business Plan 2020 competition

Klavant won the prestigious German medical technology business plan competition 2020 among approx. 50 applicants and 11 finalists. The participants qualified for the finals in a multi-stage process over half a year. Around 60 experts were involved in evaluating the participating startups.


2nd place at VENTURE.Med 2020 competition

At the hybrid startup pitching competition VENTURE.Med 2020 organized by Business Angel Network Germany and the initiatives ProRuhrgebiet and Digital Economy of NRW, Klavant won the 2nd place. From around 60 participants, the 30-person screening committee selected the TOP 10 as finalists, who were able to present their business ideas in Cologne. Klavant convinced both the expert panel on site and the more than 100 investors who took part in the event online and who were able to vote for their favorites.

Interested in clinical partnerships or receiving our abstract?

Please contact us:
Phone: +49 (0) 571 / 783 419 – 0